Cetera Advisor Networks’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$13.8M Buy
201,426
+21,252
+12% +$1.37M 0.07% 294
2023
Q4
$10.4M Buy
180,174
+667
+0.4% +$35.6K 0.06% 338
2023
Q3
$9.48M Buy
179,507
+113,697
+173% +$5.96M 0.06% 329
2023
Q2
$3.56M Sell
65,810
-307
-0.5% -$16K 0.02% 641
2023
Q1
$3.31M Buy
66,117
+3,483
+6% +$164K 0.02% 654
2022
Q4
$2.9M Buy
62,634
+7,016
+13% +$304K 0.02% 660
2022
Q3
$2.15M Buy
55,618
+1,247
+2% +$50K 0.03% 558
2022
Q2
$2.03M Buy
54,371
+29,068
+115% +$1.18M 0.03% 583
2022
Q1
$1.12M Buy
25,303
+49
+0.2% +$2.12K 0.01% 859
2021
Q4
$1.07M Buy
25,254
+3,659
+17% +$154K 0.01% 869
2021
Q3
$937K Sell
21,595
-3,717
-15% -$164K 0.01% 876
2021
Q2
$1.08M Buy
25,312
+5,399
+27% +$227K 0.02% 797
2021
Q1
$770K Sell
19,913
-7,616
-28% -$288K 0.02% 684
2020
Q4
$990K Sell
27,529
-10,741
-28% -$387K 0.02% 541
2020
Q3
$1.46M Buy
38,270
+1,257
+3% +$48.4K 0.04% 375
2020
Q2
$1.3M Buy
37,013
+5,895
+19% +$212K 0.03% 398
2020
Q1
$1.01M Buy
31,118
+973
+3% +$38K 0.03% 405
2019
Q4
$1.37M Sell
30,145
-521
-2% -$21.8K 0.04% 403
2019
Q3
$1.24M Buy
30,666
+9,814
+47% +$416K 0.04% 400
2019
Q2
$893K Buy
20,852
+9,471
+83% +$364K 0.03% 497
2019
Q1
$440K Buy
11,381
+734
+7% +$28K 0.01% 713
2018
Q4
$375K Buy
10,647
+193
+2% +$7K 0.01% 672
2018
Q3
$405K Buy
+10,454
New +$365K 0.01% 710

Other funds holding BSX

Cetera Advisor Networks's BSX Position: Q1 2024 in Review

Cetera Advisor Networks increased its Boston Scientific (BSX) stake by 12% in Q1 2024, buying an estimated $1.37M and bringing the position to 201,426 shares worth $13.8M. The position accounts for 0.07% of the portfolio, ranked #294.

Cetera Advisor Networks first reported a position in BSX in Q3 2018 and has held it in 23 quarters since. 1,223 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Cetera Advisor Networks held 201,426 shares of Boston Scientific worth $13.8M as of Q1 2024.
  • Cetera Advisor Networks bought 21,252 Boston Scientific shares in Q1 2024, an estimated $1.37M.
  • Boston Scientific made up 0.07% of Cetera Advisor Networks's portfolio in Q1 2024, its #294 holding.
  • Cetera Advisor Networks first reported a position in Boston Scientific in Q3 2018 and has held it in 23 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.